Aarti Pharmalabs Limited (NSE:AARTIPHARM)

India · Delayed Price · Currency is INR

719.90

+10.70 (1.51%)

Feb 16, 2026, 1:20 PM IST

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2023	FY 2022
Period Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Pharmaceutical	18.53B
Pharmaceutical Growth	-4.76%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2023	FY 2022
Period Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	9.74B
India Growth	-49.91%
International	8.44B
Global	345.14M